Geode Capital Management, LLC Soma Logic, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.76 - $2.83 $344,484 - $553,915	195,730 Added 6.01%	3,452,144 $8.73 Million
Q3 2023 Nov 13, 2023	BUY	$1.99 - $2.45 $248,095 - $305,443	124,671 Added 3.98%	3,256,414 $7.78 Million
Q2 2023 Aug 11, 2023	BUY	$2.1 - $3.36 $226,587 - $362,540	107,899 Added 3.57%	3,131,743 $7.23 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $235,569 - $398,145	110,596 Added 3.8%	3,023,844 $7.71 Million
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $347,837 - $588,779	169,677 Added 6.18%	2,913,248 $7.31 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $61,780 - $536,415	98,065 Added 3.71%	2,743,571 $7.96 Million
Q2 2022 Aug 12, 2022	BUY	$4.27 - $8.26 $5.22 Million - $10.1 Million	1,221,572 Added 85.79%	2,645,506 $12 Million
Q1 2022 May 13, 2022	BUY	$7.07 - $11.62 $197,373 - $324,395	27,917 Added 2.0%	1,423,934 $11.4 Million
Q4 2021 Feb 11, 2022	BUY	$10.49 - $14.28 $14.1 Million - $19.2 Million	1,346,462 Added 2717.11%	1,396,017 $16.2 Million
Q3 2021 Nov 12, 2021	BUY	$9.94 - $12.77 $492,576 - $632,817	49,555 New	49,555 $613,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.